Author

Tata Nageswara Rao

Kantonsspital St. GallenORCID 0000-0002-9928-5944Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Fabian M. KiesslingiD· 2 shared Marcelo A. S. ToledoiD· 2 shared Steffen KoschmiederiD· 2 shared Adam BenabidiD· 1 shared Aleksandar V. Kargaliev· 1 shared Alessandro MottaiD· 1 shared Alessia Nucci· 1 shared Alexandros Marios SofiasiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Fabian M. KiesslingORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Melatonin nanoparticles inhibit mutant hematopoiesis and restore bone marrow architecture in myeloproliferative neoplasms

Siddharth Gupta, Alessandro Motta, Sara Elsafy, Shiva Khorshid, Alessia Nucci, Vishrutha Sampath, Ananya Bhattacharjee, Margherita Vieri, Kathrin Olschok, Kristina Pannen, Jelena Lazarevic, Maria Jimena Rodriguez, Patrick Weiand, Venkatakrishnan Hariharan, Cristina Baquero López, , Nicolas Chatain

This study shows that melatonin nanoparticles reduce myeloproliferative neoplasm symptoms by targeting metabolic, inflammatory, and fibrotic pathways.

bioRxiv · Aug 31, 2026 · PreprintCancer Biology

Oncodevelopmental plasticity of the skeleton in myeloid neoplasms

Salim Atakhanov, Ian Ghezzi, Hector Tejeda Mora, Lucas Greven, Marta Rizk, Lina Schmidt, Katrin Goetz, Lina Merg, Valeria Solozobova, Adam Benabid, Pia Wanner, Niklas Lutterbach, Aleksandar V. Kargaliev, Mathias Schäfersküpper, Alexandru Florea, , Rebekka K. Schneider

This study identifies a novel mechanism in myelofibrosis where a single mutation drives both bone formation and resorption, revealing THBS1 as a therapeutic target.

bioRxiv · Mar 21, 2026 · PreprintCancer Biology